David Rotella

David is the Sokol Professor of Chemistry at Montclair State University where his NIH funded laboratory is actively engaged in drug discovery for CNS and parasitic disease. While in the pharmaceutical industry at Cephalon, Bristol Myers, and Wyeth he participated in and led programs in a variety of therapeutic areas that provided four clinical candidates for CNS, metabolic and cardiovascular disease.